FinscoFinsco

Globus Medical (US.GMED)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.GMED · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion80.4%→
ROE2.6%↑
Cash Conversion162.8%↓
D/E Ratio0.02↓
Gross Margin69.2%→
US.GMED (Globus Medical) | YoY: 2026 Q1 vs 2025 Q1


Metric            Value  YoY
----------------------------
FCF Conversion    80.4%    →
ROE                2.6%    ↑
Cash Conversion  162.8%    ↓
D/E Ratio          0.02    ↓
Gross Margin      69.2%    →
Key Metrics
US.GMED (Globus Medical) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
----------------------------
FCF Conversion 80.4% →
ROE 2.6% ↑
Cash Conversion 162.8% ↓
D/E Ratio 0.02 ↓
Gross Margin 69.2% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies